In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).
Astec Lifesciences's net current asset value per share for the quarter that ended in Mar. 2026 was ₹-48.67.
The historical rank and industry rank for Astec Lifesciences's Net Current Asset Value or its related term are showing as below:
During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of Astec Lifesciences was 418.75. The lowest was 115.03. And the median was 223.04.
NSE:ASTEC's Price-to-Net-Current-Asset-Value is not ranked *
in the Agriculture industry.
Industry Median: 3.52 * Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
Astec Lifesciences (NSE:ASTEC) Net Current Asset Value Explanation
Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."
The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]
Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.
One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Grahams strategy produced similar results.
Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.
Astec Lifesciences Net Current Asset Value Related Terms
Astec Lifesciences Net Current Asset Value Historical Data
* Premium members only.
The historical data trend for Astec Lifesciences's Net Current Asset Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTEC vs CTVA, CF, MOS: Net Current Asset Value Comparison
For the Agricultural Inputs subindustry, Astec Lifesciences's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Astec Lifesciences Price-to-Net-Current-Asset-Value vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Astec Lifesciences's Price-to-Net-Current-Asset-Value distribution charts can be found below:
* The bar in red indicates where Astec Lifesciences's Price-to-Net-Current-Asset-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Net Current Asset Value of ₹-48.67 mean?
Astec Lifesciences (NSE:ASTEC) has a Net Current Asset Value of ₹-48.67 as of Mar. 2026. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Astec Lifesciences and its competitors. Over the past decade, Astec Lifesciences' Net Current Asset Value has ranged from 115.03 to 418.75. According to the industry distribution chart, Astec Lifesciences ranks #999999 out of 162 companies in the Agriculture industry.
Is Astec Lifesciences' Net Current Asset Value too high?
Astec Lifesciences' current Net Current Asset Value is ₹-48.67. Over the past 10 years, this metric has ranged from a low of 115.03 to a high of 418.75. Based on the distribution chart, Astec Lifesciences ranks #999999 out of 162 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Astec Lifesciences has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Astec Lifesciences' Net Current Asset Value compare to CTVA and CF?
According to the Agriculture industry distribution chart, Astec Lifesciences ranks #999999 out of 162 companies for Net Current Asset Value. This places Astec Lifesciences in the lower half of its industry. The industry median Net Current Asset Value is 3.52. Historically, Astec Lifesciences' own Net Current Asset Value has ranged from 115.03 to 418.75 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for an Agriculture company?
The median Net Current Asset Value among Agriculture companies is 3.52, based on 162 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Astec Lifesciences and its competitors. For the Agriculture industry, the median Net Current Asset Value is 3.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Astec Lifesciences's current Net Current Asset Value is ₹-48.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astec Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Astec Lifesciences (NSE:ASTEC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹987.00, compared to a current price of ₹699.40 — trading 29.1% below its estimated fair value. The current Net Current Asset Value is ₹-48.67. Astec Lifesciences' overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Astec Lifesciences (NSE:ASTEC), the current Net Current Asset Value is ₹-48.67 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Astec Lifesciences (NSE:ASTEC) Overvalued in 2026?
Based on GuruFocus' analysis, Astec Lifesciences stock appears to be undervalued.
The current stock price of ₹699.40 is trading 29.1% below its estimated GF Value™ of ₹987.00.
GuruFocus considers Astec Lifesciences to be Modestly Undervalued.
Key valuation signals for NSE:ASTEC:
Net Current Asset Value: ₹-48.67
GF Value™: ₹987.00 vs. price of ₹699.40 (29.1% below fair value)
No single metric tells the full story. See the NSE:ASTEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Astec Lifesciences Ltd manufactures & distributes a wide range of Agrochemical active ingredients and pharmaceutical intermediates. The company's products include agrochemicals, such as Triazole Fungicides, Herbicides, and Insecticides. The company is also into Intermediates & Specialty chemicals. Geographically, all the operations of the firm function through India; however, its products are sold in the Indian and overseas markets. It operates in the business segment of Agrochemicals and has a business presence in India and outside India.
78GF Score
Get the complete analysis for NSE:ASTEC
Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTEC has been successfully added to your 
